Vaxcyte, Inc. (PCVX) analyst actions
Rating and price-target actions on PCVX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PCVX overview →
1 measured PCVX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants | Press release | +0.35% | -0.79% |
Keep exploring
More PCVX: earnings → · SEC filings → · PCVX overview →